Research Article

Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response

Table 5

The relationship between parameters and survival in patients with mGPS = 1 .

ParameterPatients Univariate Multivariate
HR (95% CI) valueHR (95% CI) value

Age
  <60/60–69/70–79/≥8033/71/89/281.24 (1.09–1.40)0.001
Sex
 Male17410.171
 Female1300.84 (0.66–1.08)
Centre
 Aberdeen14510.425
 Fife230.89 (0.55–1.43)
 Stobhill550.99 (0.72–1.36)
 Inverclyde671.23 (0.92–1.66)
Deprivation (quintile) (most deprived = 1, least deprived = 5)
 1/2/3/4/575/47/75/77/300.99 (0.90–1.08)0.777
Smoking history (NS = never smoker, otherwise pack years)
 NS/<20/20–60/>6011/33/177/691.02 (0.86–1.22)0.792
Performance status
 0/1/2/3/426/130/105/40/31.83 (1.57–2.14)<0.0011.81 (1.55–2.13)<0.001
Weight loss (% body weight)
 0/<5/5–10/>10181/48/53/221.15 (1.06–1.25)0.001
FEV1 (%)
 >80/80–60/59–40/<40138/31/45/70.94 (0.83–1.06)0.313
Local symptoms
 No/yes18/2221.60 (0.91–2.80)0.105
Stage
 NSCLC
  I/II/IIIa/IIIb/IV15/19/20/56/841.31 (1.19–1.45)<0.0011.08 (1.03–1.13)0.002
 SCLC
  Limited/extensive10/320.51 (0.23–1.11)0.091
Treatment
 Radical
  BSC/surgery/RT43/17/150.55 (0.41–0.72)<0.0010.70 (0.52–0.94)0.017
 Palliative
  Chemo/RT/BSC107/58/551.07 (0.90–1.26)0.436